Petr Kašpárek

1.5k citations
42 papers · 666 indexed · h-index 16
Topics
CRISPR and Genetic Engineering (4 papers)Peptidase Inhibition and Analysis (4 papers)Genetic Syndromes and Imprinting (3 papers)

In The Last Decade

Petr Kašpárek

41 papers receiving 656 citations

Peers

Petr Kašpárek
Comparison fields: 5 of 83
  • Molecular Biology 372
  • Genetics 103
  • Ecology 86
  • Cell Biology 85
  • Oncology 64
Replace Gillian E. Wu with:
Gillian E. Wu Canada
Laura Carramolino Spain
François Van Laethem United States
Stephen J. Terry United Kingdom
Rafael Villasmil United States
Shu‐Yi Wei Taiwan
T. Wilson United States
Hanna‐Mari Pallari Finland
David Langlais Canada
David G. Ryan United States
Petr Kašpárek relative to Gillian E. Wu Canada Gillian E. Wu's profile →
Citations per field
00.5×7.8×
Gillian E. Wu · 1×
Citations per year

Countries citing papers authored by Petr Kašpárek

Since Specialization
Citations

This map shows the geographic impact of Petr Kašpárek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Kašpárek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Kašpárek more than expected).

Fields of papers citing papers by Petr Kašpárek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Kašpárek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Kašpárek. The network helps show where Petr Kašpárek may publish in the future.

Co-authorship network of co-authors of Petr Kašpárek

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Kašpárek. A scholar is included among the top collaborators of Petr Kašpárek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Kašpárek. Petr Kašpárek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 7
4 1
5 22
6 12
7 0
8 6
9 2
10 7
11 23
12 20
13 13
14 38
15 6
16 36
17 64
18 22
19 5
20 70

About Petr Kašpárek

Petr Kašpárek is a scholar working on Immunology and Allergy, Molecular Biology and Microbiology, having authored 42 papers that have together received 666 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Peptidase Inhibition and Analysis (4 papers) and Genetic Syndromes and Imprinting (3 papers). The work is most often cited by research in Immunology and Allergy (48 citations), Microbiology (49 citations) and Molecular Biology (372 citations). Petr Kašpárek has collaborated with scholars based in Czechia, Germany and United States. Frequent co-authors include Radislav Sedláček, Jiřı́ Doškař, Vladislava Růžičková, Roman Pantůček, Oldřích Benada, Ivan Kanchev, Karel Chalupský, Jan Procházka, Stanislav Rosypal and Vladimír Kořínek. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026